Chikungunya spreads in the US: 5 things doctors won't tell you about this bone-breaking disease

Not long ago, chikungunya felt like a far-off problem, something that happened in tropical countries with mosquito trouble. But now, this virus has quietly made its way into parts of the US, and the rise in cases is starting to concern health authorities.
Chikungunya, which has been nicknamed as the “bone-breaking fever,” isn’t just another mosquito-borne disease. It creeps in with a minor twitch in the foot fingers, shows up with a fever that vanishes in a couple of days, and then leaves behind pain that can stick around for months or even years.
Even as news breaks about the spread and the vaccine (Ixchiq) being advised against for older travellers, especially after reports of heart and brain complications, there’s still so much that isn’t commonly discussed.
Here are 5 lesser-known, but very real, truths about chikungunya that most doctors don’t usually share.

Most stories of chikungunya begin with something oddly harmless — a slight twitch in the toes or fingers. That’s when the virus starts to settle in. The fever that follows usually lasts for 2 to 3 days and might even seem mild at first glance.

But then comes the rash, often mistaken for dengue, and the real ordeal begins. What’s usually hidden behind hospital curtains is how the pain doesn’t strike all at once. It chooses. For one person, it’s the knees; for another, the wrists. Every case feels like a fingerprint — different and personal.

Typical recovery advice includes resting up or trying gentle movement. But here’s the catch — in chikungunya, both rest and motion can worsen the pain. Staying still makes the joints stiff, but walking or lifting even a cup feels like a shock to the bones.

Many people describe the sensation as if their limbs are made of glass, fragile and constantly under pressure. It’s this strange paradox that often goes unspoken: every choice during recovery feels wrong.

It’s easy to assume that once the fever and rash are gone, recovery should follow a neat timeline. But with chikungunya, the pain can drag on for weeks, months, and in some cases, even five years.

That’s the part most brochures and prescriptions skip. Joint inflammation can linger in waves, coming back when least expected, especially during cold weather or after too much activity. It's a constant guessing game with no clear end date.

In 2024, the U.S. government began recommending the chikungunya vaccine Ixchiq for people travelling to high-risk countries. But just this May, both the CDC and FDA raised a red flag, particularly for people aged 60 and above.

Why? Because at least six cases of serious heart and brain-related complications were reported within a week of the shot, all in older adults. A deeper probe revealed over 10 similar cases globally. While the vaccine is made using a weakened version of the virus, in some people with underlying health issues, it appears to have triggered severe immune reactions.

So now, American health authorities advise extra caution — not a full stop, but definitely a pause — for those aged 65 and above.

There’s something rarely spoken about when it comes to chikungunya: the emotional toll. On the outside, after the fever drops, there’s no bandage, no visible sign of damage — just someone who moves slowly, winces without warning, or can't hold a pen without pain.

This disconnect leads to a strange kind of isolation. Friends and family may expect life to return to normal quickly. But the person dealing with the pain is trapped in a slow-moving body that doesn't listen anymore. This emotional struggle, layered over the physical one, often gets overlooked in clinics and conversations.